Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Endometrial Hyperplasia × Gonadotropin-Releasing Hormone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 2 Prostatic Neoplasms 1 Neoplasms 1 Inflammatory Breast Neoplasms 1 Endometrial Hyperplasia 1 Carcinoma, Ductal, Breast 1

Interventions

Letrozole 2 ricin A-GnRH conjugate 1 Progesterone 1 Medroxyprogesterone Acetate 1 LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1 Gonadotropin-Releasing Hormone 1 Cyproterone acetate, ethinyl estradiol drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03463252 2021-09-13

Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC

West China Second University Hospital

Phase 2/3 Recruiting

Endometrial Hyperplasia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡